Chronic hepatitis C infection blocks the ability of dendritic cells to secrete IFN-α and stimulate T-cell proliferation

Journal of Viral Hepatitis

Volumn 18, Issue 12, 2011, Pages 840-851

  Ryan, E J ^a   Stevenson, N J ^a   Hegarty, J E ^b   O'Farrelly, C ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

cytokines; dendritic cell; hepatitis C virus; IFN ; T cell proliferation; toll like receptor

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD86 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 29; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; RANTES; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST;

ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIVER DISEASE; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION;

AGED; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNE TOLERANCE; INTERFERON-ALPHA; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 79960940813     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01384.x     Document Type: Article

References (48)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M,. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244 (4902): 359-362. (Pubitemid 19117877)
2. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358 (9286): 958-965. (Pubitemid 32913521)
3. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW,. Aging of the hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010; 138 (2): 513-521.
4. Rehermann B,. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 2009; 119 (7): 1745-1754.
5. Neveu B, Debeaupuis E, Echasserieau K, et al. Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection. Hepatology 2008; 48 (3): 713-722.
6. Ciuffreda D, Comte D, Cavassini M, et al. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol 2008; 38 (10): 2665-2677.
7. Steinman RM,. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271-296.
8. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G,. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 2001; 120 (2): 512-524. (Pubitemid 32147649)
9. Kanto T, Hayashi N, Takehara T, et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 1999; 162 (9): 5584-5591. (Pubitemid 29307172)
10. Kanto T, Inoue M, Miyatake H, et al. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 2004; 190 (11): 1919-1926. (Pubitemid 39564696)
11. Della Bella S, Crosignani A, Riva A, et al. Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection. Immunology 2007; 121 (2): 283-292. (Pubitemid 46663097)
12. Longman RS, Talal AH, Jacobson IM, Rice CM, Albert ML,. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J Infect Dis 2005; 192 (3): 497-503. (Pubitemid 41023130)
13. Longman RS, Talal AH, Jacobson IM, Albert ML, Rice CM,. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 2004; 103 (3): 1026-1029. (Pubitemid 38129566)
14. Piccioli D, Tavarini S, Nuti S, et al. Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. J Hepatol 2005; 42 (1): 61-67. (Pubitemid 40038901)
15. Miyazaki M, Kanto T, Inoue M, et al. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I. J Med Virol 2008; 80 (6): 980-988. (Pubitemid 351657008)
16. Echeverria I, Zabaleta A, Silva L, et al. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C). J Viral Hepat 2008; 15 (11): 782-789.
17. Kenny-Walsh E,. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999; 340 (16): 1228-1233. (Pubitemid 29181642)
18. Bengtsson AK, Ryan EJ, Giordano D, Magaletti DM, Clark EA,. 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood 2004; 104 (5): 1404-1410. (Pubitemid 39166518)
19. Rowan AG, Fletcher JM, Ryan EJ, et al. Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta. J Immunol 2008; 181 (7): 4485-4494.
20. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3 (7):RESEARCH0034.
21. Tajuddin T, Ryan EJ, Norris S, Hegarty JE, O'Farrelly C,. Interferon-α suppressed granulocyte colony stimulating factor production is reversed by CL097, A TLR7/8 agonist. J Gastroenterol Hepatol 2010; doi: 10.1111/j.1440-1746.2010.06281.x.
22. Michielsen AJ, O'Sullivan JN, Ryan EJ,. Recent advances in the development of novel therapeutics targeting dendritic cells. Recent Pat Endocrine Metabolic Immune Drug Discov 2010; BSP/EMI/E-Pub/00004.
23. Makela SM, Strengell M, Pietila TE, Osterlund P, Julkunen I,. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells. J Leukoc Biol 2009; 85 (4): 664-672.
24. Li K, Foy E, Ferreon JC, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 2005; 102 (8): 2992-2997. (Pubitemid 40299904)
25. Fitzgerald KA, Rowe DC, Barnes BJ, et al. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 2003; 198 (7): 1043-1055. (Pubitemid 37248620)
26. Severa M, Remoli ME, Giacomini E, et al. Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expression. J Leukoc Biol 2006; 79 (6): 1286-1294. (Pubitemid 44835564)
27. Yonkers NL, Rodriguez B, Milkovich KA, et al. TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection. J Immunol 2007; 178 (7): 4436-4444. (Pubitemid 46492395)
28. Murakami H, Akbar SM, Matsui H, Horiike N, Onji M,. Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin Exp Immunol 2004; 137 (3): 559-565. (Pubitemid 39128083)
29. Miyatake H, Kanto T, Inoue M, et al. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection. J Viral Hepat 2007; 14 (6): 404-412. (Pubitemid 46744052)
30. Saito K, Ait-Goughoulte M, Truscott SM, et al. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. J Virol 2008; 82 (7): 3320-3328. (Pubitemid 351429910)
31. Eksioglu EA, Bess JR, Zhu H, et al. Hepatitis C virus modulates human monocyte-derived dendritic cells. J Viral Hepat 2010; 17 (11): 757-769.
32. Dolganiuc A, Chang S, Kodys K, et al. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol 2006; 177 (10): 6758-6768. (Pubitemid 44715040)
33. Golden-Mason L, Madrigal-Estebas L, McGrath E, et al. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 2008; 57 (8): 1121-1128.
34. Granucci F, Zanoni I, Pavelka N, et al. A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J Exp Med 2004; 200 (3): 287-295. (Pubitemid 39031248)
35. Ahlenstiel G, Titerence RH, Koh C, et al. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis c in an interferon-alfa- dependent manner. Gastroenterology 2010; 138 (1): 325-335.
36. Nanda KS, Ryan EJ, Murray BF, et al. Effect of chronic hepatitis C virus infection on bone disease in postmenopausal women. Clin Gastroenterol Hepatol 2009; 7 (8): 894-899.
37. Foy E, Li K, Sumpter R, Jr, et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A 2005; 102 (8): 2986-2991. (Pubitemid 40299903)
38. Navabi H, Jasani B, Reece A, et al. A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro. Vaccine 2009; 27 (1): 107-115.
39. Cooper CL, Ahluwalia NK, Efler SM, Vollmer J, Krieg AM, Davis HL,. Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers. J Immune Based Ther Vaccines 2008; 6: 3.
40. Gautier G, Humbert M, Deauvieau F, et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005; 201 (9): 1435-1446. (Pubitemid 40664087)
41. Ngoi SM, Tovey MG, Vella AT,. Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta. J Immunol 2008; 181 (11): 7670-7680.
42. Longhi MP, Trumpfheller C, Idoyaga J, et al. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med 2009; 206 (7): 1589-1602.
43. Rajagopal D, Paturel C, Morel Y, Uematsu S, Akira S, Diebold SS,. Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists. Blood 2010; 115 (10): 1949-1957.
44. MacDonald AJ, Duffy M, Brady MT, et al. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis 2002; 185 (6): 720-727. (Pubitemid 34226199)
45. Dolganiuc A, Paek E, Kodys K, Thomas J, Szabo G,. Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes. Gastroenterology 2008; 135 (6): 2119-2127.
46. Brooks DG, Ha SJ, Elsaesser H, Sharpe AH, Freeman GJ, Oldstone MB,. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc Natl Acad Sci U S A 2008; 105 (51): 20428-20433.
47. Ha SJ, Mueller SN, Wherry EJ, et al. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J Exp Med 2008; 205 (3): 543-555. (Pubitemid 351439302)
48. Boasso A, Hardy AW, Landay AL, et al. PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. Clin Immunol 2008; 129 (1): 132-144.